Meldrum, Oliver W.
Tiew, Pei Yee
Xu, Huiying
Low, Dorrain Yanwen
Ivan, Fransiskus Xaverius
Narayana, Jayanth Kumar
Jaggi, Tavleen Kaur
Ching, Jianhong
Chotirmall, Sanjay H.
Funding for this research was provided by:
LKCMedicine–ICL Fellowship ((#020458-00001)
National Research Foundation Singapore under its Open Fund-Large Collaborative Grant and administered by the Singapore Ministry of Health's National Medical Research Council (MOH-001636)
Singapore Ministry of Health's National Medical Research Council under its Clinician-Scientist Individual Research Grant (MOH-001356)
Singapore Ministry of Health's National Medical Research Council under its Clinician-Scientist Award (CSA) Investigator (INV) category (MOH-001855)
Singapore Ministry of Education under its AcRF Tier 1 Grant (RT1/22)
Article History
Received: 28 August 2025
Accepted: 22 November 2025
First Online: 28 November 2025
Declarations
:
: The study was approved by the institutional review boards of all participating hospitals and institutions through SingHealth Centralised Institutional Review Board (CIRB) and Nanyang Technological University (NTU) Review Board (Reference: CIRB 2021/2042 and NTU-IRB IRB-2021-02-040). All participants provided written informed consent prior to enrollment.
: Not applicable.
: S.H.C has served on advisory boards for CSL Behring, Pneumagen Ltd., Zaccha Pte Ltd, Boehringer-Ingelheim, GSK and Sanofi, on DSMBs for Inovio Pharmaceuticals and Imam Abdulrahman Bin Faisal University and has received personal fees from Astra-Zeneca, Boehringer-Ingelheim, CSL Behring and Chiesi Farmaceutici, all unrelated to this work. All other authors have no potential conflicts of interest to disclose.